HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$1.39
Day range
$1.40 - $1.57
Year range
$0.17 - $9.77
Market cap
36.79M USD
Avg Volume
619.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.97M | 5.18% |
Net income | -7.90M | -3.51% |
Net profit margin | — | — |
Earnings per share | -0.36 | 34.55% |
EBITDA | -7.89M | -5.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 32.33M | 41.01% |
Total assets | 44.38M | 18.88% |
Total liabilities | 23.75M | -9.93% |
Total equity | 20.63M | — |
Shares outstanding | 22.22M | — |
Price to book | 1.49 | — |
Return on assets | -41.54% | — |
Return on capital | -45.09% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -7.90M | -3.51% |
Cash from operations | -7.19M | 13.45% |
Cash from investing | -168.00K | -265.22% |
Cash from financing | 450.00K | 922.73% |
Net change in cash | -6.90M | 16.87% |
Free cash flow | -4.81M | 14.29% |
About
Founded
2011
Headquarters
Website
Employees
17